PHOENIX group headed for CTSE Europe Milan
Press Release | PHOENIX group
FEBRUARY 28, 2019
Mannheim, Germany: – Leading European integrated healthcare provider PHOENIX group will be a high-profile presence at the upcoming Clinical Trial Supply & Temperature Maintenance of Biopharmaceuticals Europe conference (CTSE 2019) in Milan.
This marks a return to Milan for PHOENIX group, which has been a consistent exhibitor at previous CTSE events to strengthen its position as Service Provider for Clinical Trial Supply Services.
The PHOENIX group stand at booth 42 will showcase the wide range of its integrated healthcare and distribution portfolio.
Offerings on display will include the tailored PHOENIX Clinical Trial Supply Services and the distinctive All-in-One offering that provides individual solutions for individual needs.
PHOENIX group will show clinical trials professionals how it is able to facilitate unparalleled access to all kind of comparator drugs, supported by its extensive network of fully-owned clinical trial depots across Europe, including Central and Eastern Europe.
Further information on the PHOENIX Clinical Trial Supply Services: https://www.phoenix-all-in-one.eu/en/benefits-best-practice/clinical-trial-supply-services/.
About PHOENIX group
The PHOENIX group, headquartered in Mannheim, is a leading pharmaceutical trader in Europe. Active in 27 countries, the company offers unique geographical coverage throughout Europe, making a vital contribution to comprehensive healthcare with more than 36,000 employees. The PHOENIX group’s vision is to be the best integrated healthcare provider – wherever it is active.
The PHOENIX group considers itself to be a link between manufacturer and patient. Pharmaceutical manufacturers, pharmacies, doctors, hospitals, health insurance funds, and patients across Europe can benefit from our service offering. In pharmaceutical wholesale, the PHOENIX group is active with 164 distribution centers in 27 countries and supplies pharmacies and medical institutions with drugs and other health products. Numerous other products and services for pharmacy customers complete the portfolio – from assistance in advising patients to modern goods management systems to pharmacy cooperation programmes. With around 13,500 member pharmacies, PHOENIX Pharmacy Partnership is the umbrella for our European network of 13 cooperation and partner programmes in 16 countries. Pharma Services provides services across the whole supply chain for the pharmaceutical industry. The PHOENIX group already operates around 2,500 of its own pharmacies in 14 European countries, thereby having profound knowledge of the pharmacy business. Our approximately 18,500 pharmacy employees have around 140 million customer contacts each year. They dispense approximately 315 million drug packages to patients and advise them on issues concerning pharmaceuticals and general health.
Further information about the PHOENIX group | www.phoenixgroup.eu.
About CTSE 2019
The 20th Clinical Trial Supply & Temperature Maintenance of Biopharmaceuticals Europe conference (CTSE 2019) aims to help trial sponsors and solution providers across Europe to speed clinical trials delivery, improve partnerships and resolve supply chain uncertainties.
Returning to Milan, CTSE 2019 is a two-day event, opening March 13 at the international convention complex in the city center.
The 2019 conference will focus on issues including e-labelling in expediting packaging and labelling timelines, harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and potential blockchain powered solutions.
The event is organized by Arena International with further information at: http://www.arena-international.com/ctseurope/.
Olaf Christiansen, Head of Marketing, PHOENIX group
Tel: +49 621 8505-8217